FAK regulates diverse biological processes involved in tumorigenesis, including proliferation, metastasis, angiogenesis, and the establishment of immunosuppressive tumor microenvironments, and targeting FAK is a potentially promising cancer treatment strategy. The gene discussed is PTK2; the disease is cancer.